echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > International Chemical > Issue 20, 2018 - Covestro will build a new world-class MDI plant in the USA

    Issue 20, 2018 - Covestro will build a new world-class MDI plant in the USA

    • Last Update: 2022-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    On October 9, the Supervisory Board of Covestro approved an investment plan of around EUR 1.
    5 billion to build a world-class diphenylmethane diisocyanate (MDI) plant
    in Baytown, USA.
    The investment will be the largest single investment
    in the company's history.
    The new plant will be located within the existing Baytown site at Covestro, with a capacity of 500,000 metric tons and is expected to start production
    in 2024.
    Covestro's total MDI production capacity in North America will reach around 740,000 tons, making it the largest MDI producer
    in the region.





    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.